RayzeBio Investing $173 Million for Central Indiana Operations Expansion
RayzeBio, Inc. is investing $173 million to expand its operations in central Indiana.
Indianapolis, IN, August 27, 2026 —
RayzeBio, Inc. has announced a significant investment of $173 million designated for the expansion of its operations in central Indiana. The company’s plans focus on increasing its footprint and capabilities within the region.
Specific details regarding the nature of the expanded operations were not provided in the initial announcement. Furthermore, the precise geographic location within central Indiana targeted for this expansion has not been disclosed. Information concerning the timeline for this investment, including projected start dates, construction phases, or operational launch, was also not made available.
Similarly, the company has not released details on the number of jobs expected to be created or retained as a result of this expansion, nor has it specified the types of roles or departments that will see growth. The total scope of the project, including any potential new facilities or upgrades to existing ones, remains undisclosed.
RayzeBio, Inc. is a company focused on radiopharmaceutical therapeutics. The financial commitment represents a substantial capital infusion into the central Indiana economy. Further details are anticipated as the company progresses with its expansion plans.
Story summarized from the original created by Google News on news.google.com, see more information here.
